PR.com: Business Directory, Press Releases, Jobs, Products, Services, Articles
 
Businesses Articles Press Releases Follow @PRcom
Press Release Pricing | News by Category | News by Country | News by US Region | Recent News | PR.com News on Your Site
 

Press Releases

 

ReproTech, Ltd.

Press Release


Receive press releases from ReproTech, Ltd.: By Email RSS Feeds:
ReproTech Releases Version 3.0 of Fertility Preservation App

ReproTech, Ltd., a cryobank specializing in long-term storage of human reproductive tissue (sperm, eggs, embryos and ovarian and testicular tissue), has released Version 3.0 of its free Fertility Preservation App for Apple devices.

St. Paul, MN, July 23, 2014 --(PR.com)-- ReproTech’s free App provides oncology professionals with easy to find and up to date information for their newly diagnosed cancer patients. The latest version (3.0) of the App is currently available for download to iPhone, iPod and iPad by searching Apple’s App Store for ReproTech or Fertility Preservation. A demonstration of the App may be viewed on YouTube by searching for ReproTech or Fertility Preservation. Links to the video and downloads from Google Play and the App Store are also available on at www.reprotechapp.com.

What’s new in Version 3.0:

Features custom clinic logos for Fertility Preservation Network centers.

Up-to-date clinic information added to the Fertility Clinic Search feature enabling users to search for fertility clinics in ReproTech’s nationwide network by zip code, clinic name, state and city.

New push notifications.

According to the American Cancer Society, 140,000 men and women of childbearing age are newly diagnosed with cancer each year. There often is a small window of time for them to preserve their fertility; therefore, access to cryopreservation services is extremely important. ReproTech’s ongoing campaign to promote Fertility Preservation awareness and education stresses the significance of healthcare providers discussing options for Fertility Preservation with patients at diagnosis. The American Medical Association’s (AMA) policy supports coverage by all insurance providers of fertility preservation therapies for patients requiring cancer treatments that may result in infertility. Additionally, the American Society of Clinical Oncology (ASCO) and American Society for Reproductive Medicine (ASRM) recommend the education of oncology patients about the options available to preserve their fertility.

ReproTech, Ltd.’s Fertility Preservation Network is comprised of top fertility centers around the U.S. and Caribbean. This growing network of centers provides much needed fertility preservation services to cancer patients prior to the initiation of oncology treatments. The Network now includes members in 35 states and the Caribbean. ReproTech, Ltd. also offers a sperm banking by air kit, OverNite Male, http://www.overnitemalekit.com for males who may be unable to visit a clinic due to illness or location. Financial Assistance programs are available through ReproTech, Ltd.’s Verna’s Purse programs or LIVESTRONG’s Fertility Discount programs.

About ReproTech, Ltd.
ReproTech Ltd. was founded in 1990 for the purpose of providing long-term cryostorage services and now operates regional cryostorage facilities in Florida, Minnesota, Nevada and Texas. More information on ReproTech, Ltd. is available at www.reprotech.com or 888-489-8944. Information specific to the Fertility Preservation Network and its members can be found at http://www.fertilitypreservation.com.
Contact Information
ReproTech, Ltd.
Courtney Dennewitz
888-489-8944
Contact
www.reprotech.com

Click here to view the list of recent Press Releases from ReproTech, Ltd.
Promote Your Business